InspireMD (NSPR) Enterprise Value Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -44.94% |
| Sep 30, 2025 | -44.43% |
| Jun 30, 2025 | 9.88% |
| Mar 31, 2025 | 4.40% |
| Dec 31, 2024 | -0.58% |
| Sep 30, 2024 | -2.91% |
| Jun 30, 2024 | -4.42% |
| Mar 31, 2024 | 8.30% |
| Dec 31, 2023 | -45.59% |
| Sep 30, 2023 | -58.09% |
| Jun 30, 2023 | -42.80% |
| Mar 31, 2023 | -60.08% |
| Dec 31, 2022 | -47.80% |
| Sep 30, 2022 | -43.28% |
| Jun 30, 2022 | -76.39% |
| Mar 31, 2022 | -72.58% |
| Dec 31, 2021 | -53.65% |
| Sep 30, 2021 | -48.82% |
| Jun 30, 2021 | -85.95% |
| Mar 31, 2021 | -111.76% |
| Dec 31, 2020 | -50.49% |
| Sep 30, 2020 | -31.69% |
| Jun 30, 2020 | -26.31% |
| Mar 31, 2020 | 28.44% |
| Dec 31, 2019 | 9.81% |
| Sep 30, 2019 | 11.92% |
| Jun 30, 2019 | -75.98% |
| Mar 31, 2019 | -42.69% |
| Dec 31, 2018 | -42.30% |
| Sep 30, 2018 | -20.00% |
| Jun 30, 2018 | 12.96% |
| Dec 31, 2017 | 16.18% |
| Jun 30, 2017 | 8.53% |
| Mar 31, 2017 | 14.48% |
| Dec 31, 2016 | 24.60% |
| Sep 30, 2016 | -382.83% |
| Jun 30, 2016 | 60.91% |
| Mar 31, 2016 | 7.36% |
| Dec 31, 2015 | 15.68% |
| Sep 30, 2015 | 7.77% |
| Jun 30, 2015 | 1.70% |
| Dec 31, 2014 | -7.34% |
| Jun 30, 2014 | -3.66% |
| Mar 31, 2014 | -12.54% |
| Dec 31, 2013 | -202.10% |
| Sep 30, 2013 | 52.28% |
| Jun 30, 2013 | -242.15% |